 Emmaus Life Sciences Inc OTCQX:EMMA announced that the Kuwaiti Ministry of Health has granted marketing authorization for the commercial distribution and sale of its Endari product in the Gulf country. The Torrance, California-based firm said it has received Registration Approval from the Pharmaceutical and Herbal Medicines Registration and Control Administration Drug and Food Control of the Kuwaiti Ministry of Health, making Kuwait the latest Gulf Cooperation Council country to grant full marketing approval for Endari following approvals in the United Arab Emirates and the State of Qatar earlier this year. 